Hern E P, Shroyer L A, Varandani P T
Arch Biochem Biophys. 1987 Apr;254(1):35-42. doi: 10.1016/0003-9861(87)90078-6.
The activity of the insulin-degrading enzyme neutral cysteine proteinase (EC 3.4.22.11, insulinase) was studied in adipose tissue and in liver of nondiabetic, streptozotocin-diabetic, and insulin-treated diabetic rats. Proteinase activity was found to be significantly decreased during diabetes and was restored to near normal levels in both tissues following insulin treatment. The insulin-mediated increase of proteinase activity in both tissues was partially or completely blocked by actinomycin D (an inhibitor of RNA synthesis) and by cyclohexamide (an inhibitor of protein synthesis). Kinetic analysis showed that the changes in proteinase activity of both liver and adipose tissues were accompanied by a change in Vmax (i.e., maximal enzyme activity) without a change in Km (i.e., substrate affinity). These data indicate that insulin functions as an inducer for neutral cysteine proteinase in both tissues. These alterations in the proteinase activity paralleled the alterations in the activity of a second insulin-degrading enzyme, glutathione-insulin transhydrogenase in adipose tissue (this paper) and in liver (previously published papers) under the same physiological conditions.
在非糖尿病大鼠、链脲佐菌素诱导糖尿病大鼠以及胰岛素治疗的糖尿病大鼠的脂肪组织和肝脏中,研究了胰岛素降解酶中性半胱氨酸蛋白酶(EC 3.4.22.11,胰岛素酶)的活性。发现蛋白酶活性在糖尿病期间显著降低,胰岛素治疗后两种组织中的蛋白酶活性均恢复至接近正常水平。放线菌素D(一种RNA合成抑制剂)和环己酰胺(一种蛋白质合成抑制剂)可部分或完全阻断胰岛素介导的两种组织中蛋白酶活性的增加。动力学分析表明,肝脏和脂肪组织中蛋白酶活性的变化伴随着Vmax(即最大酶活性)的变化,而Km(即底物亲和力)不变。这些数据表明,胰岛素在两种组织中均作为中性半胱氨酸蛋白酶的诱导剂发挥作用。在相同生理条件下,蛋白酶活性的这些变化与脂肪组织(本文)和肝脏(先前发表的论文)中第二种胰岛素降解酶谷胱甘肽 - 胰岛素转氢酶活性的变化平行。